These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18621624)

  • 21. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study.
    Perera FP; Mooney LA; Stampfer M; Phillips DH; Bell DA; Rundle A; Cho S; Tsai WY; Ma J; Blackwood A; Tang D;
    Carcinogenesis; 2002 Oct; 23(10):1641-6. PubMed ID: 12376472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular epidemiology of smoking and lung cancer.
    Shields PG
    Oncogene; 2002 Oct; 21(45):6870-6. PubMed ID: 12362269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tobacco and cancer: epidemiology and the laboratory.
    Vineis P; Caporaso N
    Environ Health Perspect; 1995 Feb; 103(2):156-60. PubMed ID: 7737063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender and lung cancer.
    Rivera MP; Stover DE
    Clin Chest Med; 2004 Jun; 25(2):391-400. PubMed ID: 15099898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
    Islam SS; Schottenfeld D
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology: a new perspective for the study of toxic exposures in man. A consideration of the influence of genetic susceptibility factors on risk in different lung cancer histologies.
    Caporaso NE; Landi MT
    Med Lav; 1994; 85(1):68-77. PubMed ID: 8035747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bulky DNA Adducts, Tobacco Smoking, Genetic Susceptibility, and Lung Cancer Risk.
    Munnia A; Giese RW; Polvani S; Galli A; Cellai F; Peluso MEM
    Adv Clin Chem; 2017; 81():231-277. PubMed ID: 28629590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study.
    Nitadori J; Inoue M; Iwasaki M; Otani T; Sasazuki S; Nagai K; Tsugane S
    Chest; 2006 Oct; 130(4):968-75. PubMed ID: 17035426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer incidence in never smokers.
    Wakelee HA; Chang ET; Gomez SL; Keegan TH; Feskanich D; Clarke CA; Holmberg L; Yong LC; Kolonel LN; Gould MK; West DW
    J Clin Oncol; 2007 Feb; 25(5):472-8. PubMed ID: 17290054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers.
    Tang DL; Rundle A; Warburton D; Santella RM; Tsai WY; Chiamprasert S; Hsu YZ; Perera FP
    Carcinogenesis; 1998 Nov; 19(11):1949-53. PubMed ID: 9855008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States.
    Kabat GC
    Lung Cancer; 1996 Aug; 15(1):1-20. PubMed ID: 8865119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of lung cancer in women: risk factors, survival, and screening.
    Kligerman S; White C
    AJR Am J Roentgenol; 2011 Feb; 196(2):287-95. PubMed ID: 21257878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research.
    Belani CP; Marts S; Schiller J; Socinski MA
    Lung Cancer; 2007 Jan; 55(1):15-23. PubMed ID: 17084482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of Lung Cancer.
    Schwartz AG; Cote ML
    Adv Exp Med Biol; 2016; 893():21-41. PubMed ID: 26667337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
    Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular biology of lung cancer: clinical implications.
    Fong KM; Minna JD
    Clin Chest Med; 2002 Mar; 23(1):83-101. PubMed ID: 11901922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genes associated with succeptibility to lung adenocarcinoma among never smokers suggest the mechanism of disease.
    Okazaki I; Ishikawa S; Sohara Y
    Anticancer Res; 2014 Oct; 34(10):5229-40. PubMed ID: 25275015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of lung cancer and lung cancer screening programs in China and the United States.
    Yang D; Liu Y; Bai C; Wang X; Powell CA
    Cancer Lett; 2020 Jan; 468():82-87. PubMed ID: 31600530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology of human cancer risk. Gene-environment interactions and p53 mutation spectrum in human lung cancer.
    Vähäkangas K
    Methods Mol Med; 2003; 74():43-59. PubMed ID: 12415685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.